585 related articles for article (PubMed ID: 27444882)
1. Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humans.
Thaler B; Hohensinner PJ; Krychtiuk KA; Matzneller P; Koller L; Brekalo M; Maurer G; Huber K; Zeitlinger M; Jilma B; Wojta J; Speidl WS
Sci Rep; 2016 Jul; 6():30162. PubMed ID: 27444882
[TBL] [Abstract][Full Text] [Related]
2. Monocyte Subsets Are Differentially Lost from the Circulation during Acute Inflammation Induced by Human Experimental Endotoxemia.
Tak T; van Groenendael R; Pickkers P; Koenderman L
J Innate Immun; 2017; 9(5):464-474. PubMed ID: 28641299
[TBL] [Abstract][Full Text] [Related]
3. A Novel, Five-Marker Alternative to CD16-CD14 Gating to Identify the Three Human Monocyte Subsets.
Ong SM; Teng K; Newell E; Chen H; Chen J; Loy T; Yeo TW; Fink K; Wong SC
Front Immunol; 2019; 10():1761. PubMed ID: 31402918
[TBL] [Abstract][Full Text] [Related]
4. The pro-inflammatory phenotype of the human non-classical monocyte subset is attributed to senescence.
Ong SM; Hadadi E; Dang TM; Yeap WH; Tan CT; Ng TP; Larbi A; Wong SC
Cell Death Dis; 2018 Feb; 9(3):266. PubMed ID: 29449647
[TBL] [Abstract][Full Text] [Related]
5. Maximal Exercise Alters the Inflammatory Phenotype and Response of Mononuclear Cells.
Slusher AL; Zúñiga TM; Acevedo EO
Med Sci Sports Exerc; 2018 Apr; 50(4):675-683. PubMed ID: 29112629
[TBL] [Abstract][Full Text] [Related]
6. Blood monocyte profiles in COPD patients with PiMM and PiZZ α1-antitrypsin.
Stolk J; Aggarwal N; Hochnadel I; Wrenger S; Martinez-Delgado B; Welte T; Yevsa T; Janciauskiene S
Respir Med; 2019 Mar; 148():60-62. PubMed ID: 30827477
[TBL] [Abstract][Full Text] [Related]
7. The "Intermediate" CD14
Wildgruber M; Aschenbrenner T; Wendorff H; Czubba M; Glinzer A; Haller B; Schiemann M; Zimmermann A; Berger H; Eckstein HH; Meier R; Wohlgemuth WA; Libby P; Zernecke A
Sci Rep; 2016 Dec; 6():39483. PubMed ID: 27991581
[TBL] [Abstract][Full Text] [Related]
8. Expansion and preferential activation of the CD14(+)CD16(+) monocyte subset during multiple sclerosis.
Chuluundorj D; Harding SA; Abernethy D; La Flamme AC
Immunol Cell Biol; 2014 Jul; 92(6):509-17. PubMed ID: 24638064
[TBL] [Abstract][Full Text] [Related]
9. Effect of Native and Minimally Modified Low-density Lipoprotein on the Activation of Monocyte Subsets.
Blanco-Favela F; Espinosa-Luna JE; Chávez-Rueda AK; Madrid-Miller A; Chávez-Sánchez L
Arch Med Res; 2017 Jul; 48(5):432-440. PubMed ID: 29133194
[TBL] [Abstract][Full Text] [Related]
10. Elevated circulating CD14
Peng A; Ke P; Zhao R; Lu X; Zhang C; Huang X; Tian G; Huang J; Wang J; Invernizzi P; Chen Q; Zhuang J
Clin Exp Med; 2016 Nov; 16(4):511-521. PubMed ID: 26403460
[TBL] [Abstract][Full Text] [Related]
11. Lower HDL-C levels are associated with higher expressions of CD16 on monocyte subsets in coronary atherosclerosis.
Xiang Y; Liang B; Zhang X; Zheng F
Int J Med Sci; 2020; 17(14):2171-2179. PubMed ID: 32922178
[No Abstract] [Full Text] [Related]
12. Reprint of: Alterations of TRIM21-mRNA expression during monocyte maturation.
Lenart M; Rutkowska-Zapała M; Szatanek R; Węglarczyk K; Stec M; Bukowska-Strakova K; Gruca A; Czyż J; Siedlar M
Immunobiology; 2017 Jun; 222(6):841-845. PubMed ID: 28576352
[TBL] [Abstract][Full Text] [Related]
13. CD14++CD16+ Monocytes Are Enriched by Glucocorticoid Treatment and Are Functionally Attenuated in Driving Effector T Cell Responses.
Liu B; Dhanda A; Hirani S; Williams EL; Sen HN; Martinez Estrada F; Ling D; Thompson I; Casady M; Li Z; Si H; Tucker W; Wei L; Jawad S; Sura A; Dailey J; Hannes S; Chen P; Chien JL; Gordon S; Lee RW; Nussenblatt RB
J Immunol; 2015 Jun; 194(11):5150-60. PubMed ID: 25911752
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic and functional analysis of monocyte populations in cattle peripheral blood identifies a subset with high endocytic and allogeneic T-cell stimulatory capacity.
Corripio-Miyar Y; Hope J; McInnes CJ; Wattegedera SR; Jensen K; Pang Y; Entrican G; Glass EJ
Vet Res; 2015 Sep; 46():112. PubMed ID: 26407849
[TBL] [Abstract][Full Text] [Related]
15. Circulating intermediate CD14++CD16+monocytes are increased in patients with atrial fibrillation and reflect the functional remodelling of the left atrium.
Suzuki A; Fukuzawa K; Yamashita T; Yoshida A; Sasaki N; Emoto T; Takei A; Fujiwara R; Nakanishi T; Yamashita S; Matsumoto A; Konishi H; Ichibori H; Hirata KI
Europace; 2017 Jan; 19(1):40-47. PubMed ID: 26826137
[TBL] [Abstract][Full Text] [Related]
16. SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset.
Zawada AM; Rogacev KS; Rotter B; Winter P; Marell RR; Fliser D; Heine GH
Blood; 2011 Sep; 118(12):e50-61. PubMed ID: 21803849
[TBL] [Abstract][Full Text] [Related]
17. Circulating classical CD14++CD16- monocytes predict shorter time to initial treatment in chronic lymphocytic leukemia patients: Differential effects of immune chemotherapy on monocyte-related membrane and soluble forms of CD163.
Lapuc I; Bolkun L; Eljaszewicz A; Rusak M; Luksza E; Singh P; Miklasz P; Piszcz J; Ptaszynska-Kopczynska K; Jasiewicz M; Kaminski K; Dabrowska M; Bodzenta-Lukaszyk A; Kloczko J; Moniuszko M
Oncol Rep; 2015 Sep; 34(3):1269-78. PubMed ID: 26135617
[TBL] [Abstract][Full Text] [Related]
18. Circulating CD14
Meeuwsen JAL; de Vries JJ; van Duijvenvoorde A; van der Velden S; van der Laan SW; van Koeverden ID; van de Weg SM; de Borst GJ; de Winther MPJ; Kuiper J; Pasterkamp G; Hoefer IE; de Jager SCA;
J Mol Cell Cardiol; 2019 Feb; 127():260-269. PubMed ID: 30629987
[TBL] [Abstract][Full Text] [Related]
19. CD16(+) monocyte subsets are increased in large abdominal aortic aneurysms and are differentially related with circulating and cell-associated biochemical and inflammatory biomarkers.
Ghigliotti G; Barisione C; Garibaldi S; Brunelli C; Palmieri D; Spinella G; Pane B; Spallarossa P; Altieri P; Fabbi P; Sambuceti G; Palombo D
Dis Markers; 2013; 34(2):131-42. PubMed ID: 23348634
[TBL] [Abstract][Full Text] [Related]
20. Protease-Activated Receptors 1 and 3 are Differentially Expressed on Human Monocyte Subsets and are Upregulated by Lipopolysaccharide Ex Vivo and In Vivo.
Thaler B; Hohensinner PJ; Baumgartner J; Haider P; Krychtiuk KA; Schörgenhofer C; Jilma B; Hell L; Fischer MB; Huber K; Hengstenberg C; Speidl WS; Wojta J
Thromb Haemost; 2019 Sep; 119(9):1394-1402. PubMed ID: 31291665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
